AcquisitionOther

Zymeworks Inc. acquired Theravance Biopharma.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Zymeworks Inc. -> Theravance Biopharma.

Zymeworks is a global biotechnology company building a diversified portfolio of healthcare assets designed to generate durable cash flows while advancing innovative medicines for difficult-to-treat diseases.

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk